Literature DB >> 15664403

Continuous inhalation of carbon monoxide attenuates hypoxic pulmonary hypertension development presumably through activation of BKCa channels.

Eric Dubuis1, Marie Potier, Rui Wang, Christophe Vandier.   

Abstract

OBJECTIVE: We tested the hypothesis that inhalation of a low concentration of exogenous carbon monoxide (CO) attenuates the development of hypoxic pulmonary artery hypertension by activation of large-conductance voltage and Ca(2+)-activated K(+) channels (BK(Ca)).
METHODS: The BK(Ca) activity was measured using whole-cell and inside-out patch clamp recordings in Wistar rat pulmonary artery (PA) myocytes. Pulmonary artery pressures were measured in vivo and membrane potentials were recorded in vitro in pressurized resistance arteries.
RESULTS: Chronic CO inhalation slightly increases single-channel conductance of BK(Ca) channels and induces a large increase in the sensitivity of BK(Ca) channels to Ca(2+) of PA myocytes from normoxic and chronic hypoxic rats. Consequently, BK(Ca) currents are increased and play a more prominent role in controlling resting membrane potential of PA myocytes. Chronic CO inhalation also reduces hemodynamic changes induced by chronic hypoxia and attenuates hypoxic pulmonary artery hypertension.
CONCLUSION: Chronic inhalation of CO attenuates hypoxic pulmonary artery hypertension development presumably through activation of BK(Ca) channels. These results highlight the potential use of CO as a novel avenue for research on the treatment of pulmonary artery hypertension (PAHT) in a similar manner to another gasotransmitter, nitric oxide.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15664403     DOI: 10.1016/j.cardiores.2004.11.007

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  25 in total

1.  BK channels in rat and human pulmonary smooth muscle cells are BKα-β1 functional complexes lacking the oxygen-sensitive stress axis regulated exon insert.

Authors:  Neil D Detweiler; Li Song; Samantha J McClenahan; Rachel J Versluis; Sujay V Kharade; Richard C Kurten; Sung W Rhee; Nancy J Rusch
Journal:  Pulm Circ       Date:  2016-12       Impact factor: 3.017

Review 2.  The therapeutic potential of carbon monoxide.

Authors:  Roberto Motterlini; Leo E Otterbein
Journal:  Nat Rev Drug Discov       Date:  2010-09       Impact factor: 84.694

Review 3.  [Carbon monoxide--poison or potential therapeutic?].

Authors:  A Hoetzel; R Schmidt
Journal:  Anaesthesist       Date:  2006-10       Impact factor: 1.041

Review 4.  Molecular pathogenesis and current pathology of pulmonary hypertension.

Authors:  Vinicio A de Jesus Perez
Journal:  Heart Fail Rev       Date:  2016-05       Impact factor: 4.214

Review 5.  Anesthesia-Related Carbon Monoxide Exposure: Toxicity and Potential Therapy.

Authors:  Richard J Levy
Journal:  Anesth Analg       Date:  2016-09       Impact factor: 5.108

6.  Echinacoside induces rat pulmonary artery vasorelaxation by opening the NO-cGMP-PKG-BKCa channels and reducing intracellular Ca2+ levels.

Authors:  Xiang-yun Gai; Yu-hai Wei; Wei Zhang; Ta-na Wuren; Ya-ping Wang; Zhan-qiang Li; Shou Liu; Lan Ma; Dian-xiang Lu; Yi Zhou; Ri-li Ge
Journal:  Acta Pharmacol Sin       Date:  2015-04-13       Impact factor: 6.150

Review 7.  Carbon monoxide--physiology, detection and controlled release.

Authors:  Stefan H Heinemann; Toshinori Hoshi; Matthias Westerhausen; Alexander Schiller
Journal:  Chem Commun (Camb)       Date:  2014-04-11       Impact factor: 6.222

8.  Distinct activity of BK channel β1-subunit in cerebral and pulmonary artery smooth muscle cells.

Authors:  Yun-Min Zheng; Sang Woong Park; Lindsay Stokes; Qiang Tang; Jun-Hua Xiao; Yong-Xiao Wang
Journal:  Am J Physiol Cell Physiol       Date:  2013-02-20       Impact factor: 4.249

Review 9.  Carbon monoxide in lung cell physiology and disease.

Authors:  Stefan W Ryter; Kevin C Ma; Augustine M K Choi
Journal:  Am J Physiol Cell Physiol       Date:  2017-11-08       Impact factor: 4.249

Review 10.  Bench-to-bedside review: Carbon monoxide--from mitochondrial poisoning to therapeutic use.

Authors:  Inge Bauer; Benedikt H J Pannen
Journal:  Crit Care       Date:  2009-08-14       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.